Listen to an Interview with Rob DiCicco, VP Portfolio Management, Transcelerate Biopharma Inc. and Editor-in-Chief, Donna W. Dorozinsky, R.N., M.S.N., C.C.R.C., as she discusses what's new in this edition, including new chapters, integrated global content, and our expert editorial team.
In the past several years we have seen the release of many new regulations and guidances throughout the world. We are coming out of a pandemic which has changed how we conduct and manage clinical trials, and we are dealing with an unstable world where research subjects are living in war torn regions. The 2024/2025 edition of Barnett’s Good Clinical Practice: A Question & Answer Reference Guide has been reorganized with added topics to address this new era of clinical research. Written by more than 20 subject matter experts in core clinical research areas, this industry-leading GCP reference guide answers over 1,500 of the most common and difficult questions regarding the interpretation and implementation of U.S. and international GCP standards for drugs, biologics, and medical device clinical trials.
Some highlights of the completely updated and expanded guide include: